{"id":54116,"date":"2026-01-14T21:48:54","date_gmt":"2026-01-14T13:48:54","guid":{"rendered":"https:\/\/flcube.com\/?p=54116"},"modified":"2026-01-14T21:48:56","modified_gmt":"2026-01-14T13:48:56","slug":"astrazeneca-acquires-modella-ai-to-embed-multi-modal-foundation-models-in-oncology-rd","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=54116","title":{"rendered":"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D"},"content":{"rendered":"\n<p><strong>AstraZeneca plc<\/strong> (AZ, <a href=\"https:\/\/www.google.com\/finance\/quote\/AZN:NASDAQ\">NASDAQ:\u202fAZN<\/a>) announced the acquisition of <strong>Modella AI<\/strong>, a leader in artificial intelligence for life sciences, to integrate <strong>multi\u2011modal AI foundation models and AI agents<\/strong> across its global oncology portfolio. The deal follows a multi\u2011year agreement announced in July\u202f2025 and will embed Modella AI\u2019s generative and agentic platform into AstraZeneca\u2019s oncology research and development organization.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-structure\">Deal Structure<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Acquirer<\/strong><\/td><td>AstraZeneca plc (NASDAQ:\u202fAZN)<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Modella AI<\/td><\/tr><tr><td><strong>Acquisition Type<\/strong><\/td><td>Full acquisition (financial terms not disclosed)<\/td><\/tr><tr><td><strong>Strategic Rationale<\/strong><\/td><td>Integrate multi\u2011modal foundation models and AI agents into oncology R&amp;D<\/td><\/tr><tr><td><strong>Prior Relationship<\/strong><\/td><td>Multi\u2011year collaboration announced July\u202f2025<\/td><\/tr><tr><td><strong>Key Objectives<\/strong><\/td><td>Accelerate clinical development, enhance biomarker discovery, enable data\u2011driven decision\u2011making<\/td><\/tr><tr><td><strong>Technology Scope<\/strong><\/td><td>Generative AI, agentic AI, multi\u2011modal foundation models<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-profile-amp-integration\">Technology Profile &amp; Integration<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Platform:<\/strong> Modella AI\u2019s <strong>multi\u2011modal foundation models<\/strong> process diverse data types (genomics, imaging, clinical notes) to generate novel biological insights<\/li>\n\n\n\n<li><strong>AI Agents:<\/strong> <strong>Agentic AI<\/strong> automates complex R&amp;D workflows, enabling <strong>scalable, consistent analysis<\/strong> across data\u2011intensive pipelines<\/li>\n\n\n\n<li><strong>Oncology Focus:<\/strong> Integration aims to <strong>shorten drug discovery timelines<\/strong> and <strong>improve clinical trial success rates<\/strong> through predictive modeling and biomarker identification<\/li>\n\n\n\n<li><strong>Competitive Edge:<\/strong> AstraZeneca becomes <strong>first major pharma<\/strong> to fully acquire and internalize a generative AI platform purpose\u2011built for oncology<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-ai-in-drug-discovery-landscape\">Market Impact &amp; AI in Drug Discovery Landscape<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>2026E<\/th><th>2027E<\/th><th>2028E<\/th><\/tr><\/thead><tbody><tr><td><strong>Global AI\u2011Driven Drug Discovery Market<\/strong><\/td><td>$5.2\u202fbillion<\/td><td>$7.8\u202fbillion<\/td><td>$11.4\u202fbillion<\/td><\/tr><tr><td><strong>Oncology AI Share<\/strong><\/td><td>42\u202f%<\/td><td>45\u202f%<\/td><td>48\u202f%<\/td><\/tr><tr><td><strong>AstraZeneca R&amp;D Spend<\/strong><\/td><td>$9.8\u202fbillion<\/td><td>$10.5\u202fbillion<\/td><td>$11.2\u202fbillion<\/td><\/tr><tr><td><strong>AI\u2011Enabled Savings (% of R&amp;D)<\/strong><\/td><td>8\u202f%<\/td><td>12\u202f%<\/td><td>15\u202f%<\/td><\/tr><tr><td><strong>Modella AI Revenue Impact<\/strong><\/td><td>Integrated<\/td><td>Cost avoidance: $780\u202fM<\/td><td>Cost avoidance: $1.65\u202fB<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Competition:<\/strong><\/li>\n\n\n\n<li><strong>Roche<\/strong> \u2013 Internal AI platform (not acquired)<\/li>\n\n\n\n<li><strong>Novartis<\/strong> \u2013 Partnerships with Microsoft, NVIDIA<\/li>\n\n\n\n<li><strong>Insilico Medicine<\/strong> \u2013 Standalone AI biotech (not integrated)<\/li>\n\n\n\n<li><strong>Differentiation:<\/strong> <strong>Full ownership<\/strong> provides <strong>data sovereignty<\/strong> and <strong>customization<\/strong> unavailable through partnerships<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning\">Strategic Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pipeline Acceleration:<\/strong> Modella AI will support <strong>AstraZeneca\u2019s 20+ late\u2011stage oncology assets<\/strong>, including <strong>datopotamab deruxtecan<\/strong> and <strong>camizestrant<\/strong><\/li>\n\n\n\n<li><strong>Biomarker Discovery:<\/strong> Enhanced identification of <strong>predictive biomarkers<\/strong> for <strong>Tagrisso, Imfinzi, and Lynparza<\/strong> combinations<\/li>\n\n\n\n<li><strong>Automation:<\/strong> AI agents to automate <strong>clinical trial data cleaning, patient recruitment modeling, and real\u2011world evidence generation<\/strong><\/li>\n\n\n\n<li><strong>Global Deployment:<\/strong> Technology will be implemented across AstraZeneca\u2019s <strong>R&amp;D sites in Cambridge (UK), Gaithersburg (US), and Shanghai (China)<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding AI integration timelines, R&amp;D cost savings, and competitive advantages from the Modella AI acquisition. Actual results may differ due to technology integration challenges, data quality issues, and competitive responses.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca plc (AZ, NASDAQ:\u202fAZN) announced the acquisition of Modella AI, a leader in artificial intelligence&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,130,4206,871],"class_list":["post-54116","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-ai","tag-astrazeneca","tag-modella-ai","tag-nasdaq-azn"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"AstraZeneca plc (AZ, NASDAQ:\u202fAZN) announced the acquisition of Modella AI, a leader in artificial intelligence for life sciences, to integrate multi\u2011modal AI foundation models and AI agents across its global oncology portfolio. The deal follows a multi\u2011year agreement announced in July\u202f2025 and will embed Modella AI\u2019s generative and agentic platform into AstraZeneca\u2019s oncology research and development organization.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=54116\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D\" \/>\n<meta property=\"og:description\" content=\"AstraZeneca plc (AZ, NASDAQ:\u202fAZN) announced the acquisition of Modella AI, a leader in artificial intelligence for life sciences, to integrate multi\u2011modal AI foundation models and AI agents across its global oncology portfolio. The deal follows a multi\u2011year agreement announced in July\u202f2025 and will embed Modella AI\u2019s generative and agentic platform into AstraZeneca\u2019s oncology research and development organization.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=54116\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-14T13:48:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-14T13:48:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54116#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54116\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D\",\"datePublished\":\"2026-01-14T13:48:54+00:00\",\"dateModified\":\"2026-01-14T13:48:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54116\"},\"wordCount\":421,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"AstraZeneca\",\"Modella AI\",\"NASDAQ: AZN\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54116#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54116\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=54116\",\"name\":\"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-14T13:48:54+00:00\",\"dateModified\":\"2026-01-14T13:48:56+00:00\",\"description\":\"AstraZeneca plc (AZ, NASDAQ:\u202fAZN) announced the acquisition of Modella AI, a leader in artificial intelligence for life sciences, to integrate multi\u2011modal AI foundation models and AI agents across its global oncology portfolio. The deal follows a multi\u2011year agreement announced in July\u202f2025 and will embed Modella AI\u2019s generative and agentic platform into AstraZeneca\u2019s oncology research and development organization.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54116#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54116\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54116#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D - Insight, China&#039;s Pharmaceutical Industry","description":"AstraZeneca plc (AZ, NASDAQ:\u202fAZN) announced the acquisition of Modella AI, a leader in artificial intelligence for life sciences, to integrate multi\u2011modal AI foundation models and AI agents across its global oncology portfolio. The deal follows a multi\u2011year agreement announced in July\u202f2025 and will embed Modella AI\u2019s generative and agentic platform into AstraZeneca\u2019s oncology research and development organization.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=54116","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D","og_description":"AstraZeneca plc (AZ, NASDAQ:\u202fAZN) announced the acquisition of Modella AI, a leader in artificial intelligence for life sciences, to integrate multi\u2011modal AI foundation models and AI agents across its global oncology portfolio. The deal follows a multi\u2011year agreement announced in July\u202f2025 and will embed Modella AI\u2019s generative and agentic platform into AstraZeneca\u2019s oncology research and development organization.","og_url":"https:\/\/flcube.com\/?p=54116","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-14T13:48:54+00:00","article_modified_time":"2026-01-14T13:48:56+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=54116#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=54116"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D","datePublished":"2026-01-14T13:48:54+00:00","dateModified":"2026-01-14T13:48:56+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=54116"},"wordCount":421,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","AstraZeneca","Modella AI","NASDAQ: AZN"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=54116#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=54116","url":"https:\/\/flcube.com\/?p=54116","name":"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-14T13:48:54+00:00","dateModified":"2026-01-14T13:48:56+00:00","description":"AstraZeneca plc (AZ, NASDAQ:\u202fAZN) announced the acquisition of Modella AI, a leader in artificial intelligence for life sciences, to integrate multi\u2011modal AI foundation models and AI agents across its global oncology portfolio. The deal follows a multi\u2011year agreement announced in July\u202f2025 and will embed Modella AI\u2019s generative and agentic platform into AstraZeneca\u2019s oncology research and development organization.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=54116#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=54116"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=54116#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca Acquires Modella AI to Embed Multi\u2011Modal Foundation Models in Oncology R&amp;D"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=54116"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54116\/revisions"}],"predecessor-version":[{"id":54117,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54116\/revisions\/54117"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=54116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=54116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=54116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}